P45.01 Therapeutic effectiveness of Lorlatinib After Alectinib in Japanese Patients With ALK-Positive NSCLC in Real-World

Y. Goto,B. Emir, K. Kaneyasu, H. Kikkawa, R. Wiltshire, T. Shukuya

Journal of Thoracic Oncology(2021)

引用 0|浏览0
暂无评分
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要